When is varicella-zoster immune globulin (VariZIG) indicated?

Updated: Aug 31, 2020
  • Author: Anthony J Papadopoulos, MD; Chief Editor: Dirk M Elston, MD  more...
  • Print

Varicella-zoster immune globulin (VariZIG) is indicated for use in highly susceptible, VZV-exposed immunocompromised or immunosuppressed populations. A live attenuated varicella vaccine (Oka strain) was approved by the FDA in 1995 for prophylactic use in healthy children and adults. [22, 23, 24, 25, 26]

While the current standard of care is with the antiviral agents discussed below, Lysimachia mauritiana extract appears promising as a potential agent. [27]

Also see the Guidelines section.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!